Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2020 Sep 8;14(9):e0008613. doi: 10.1371/journal.pntd.0008613

Redefining enteroaggregative Escherichia coli (EAEC): Genomic characterization of epidemiological EAEC strains

Nadia Boisen 1,*, Mark T Østerlund 1, Katrine G Joensen 1, Araceli E Santiago 2, Inacio Mandomando 3, Alejandro Cravioto 4, Marie A Chattaway 5, Laura A Gonyar 2, Søren Overballe-Petersen 1, O Colin Stine 6, David A Rasko 7, Flemming Scheutz 1, James P Nataro 2
Editor: Claire Jenkins8
PMCID: PMC7500659  PMID: 32898134

Abstract

Although enteroaggregative E. coli (EAEC) has been implicated as a common cause of diarrhea in multiple settings, neither its essential genomic nature nor its role as an enteric pathogen are fully understood. The current definition of this pathotype requires demonstration of cellular adherence; a working molecular definition encompasses E. coli which do not harbor the heat-stable or heat-labile toxins of enterotoxigenic E. coli (ETEC) and harbor the genes aaiC, aggR, and/or aatA. In an effort to improve the definition of this pathotype, we report the most definitive characterization of the pan-genome of EAEC to date, applying comparative genomics and functional characterization on a collection of 97 EAEC strains isolated in the course of a multicenter case-control diarrhea study (Global Enteric Multi-Center Study, GEMS). Genomic analysis revealed that the EAEC strains mapped to all phylogenomic groups of E. coli. Circa 70% of strains harbored one of the five described AAF variants; there were no additional AAF variants identified, and strains that lacked an identifiable AAF generally did not have an otherwise complete AggR regulon. An exception was strains that harbored an ETEC colonization factor (CF) CS22, like AAF a member of the chaperone-usher family of adhesins, but not phylogenetically related to the AAF family. Of all genes scored, sepA yielded the strongest association with diarrhea (P = 0.002) followed by the increased serum survival gene, iss (p = 0.026), and the outer membrane protease gene ompT (p = 0.046). Notably, the EAEC genomes harbored several genes characteristically associated with other E. coli pathotypes. Our data suggest that a molecular definition of EAEC could comprise E. coli strains harboring AggR and a complete AAF(I-V) or CS22 gene cluster. Further, it is possible that strains meeting this definition could be both enteric bacteria and urinary/systemic pathogens.

Author summary

Enteroaggregative E. coli (EAEC) has been implicated as a common cause of diarrhea in multiple settings and associated with linear growth faltering among children in low-income countries. Unlike other E. coli pathotypes EAEC stands alone in employing a phenotypic, rather than genotypic, definition. Therefore, the lack of a formally recognized genetic definition for EAEC serves to complicate its epidemiologic investigation. In an effort to improve the definition of this pathotype, we generated the most definitive characterization of the pan-genome of EAEC by performing whole genome sequencing on a collection of strains isolated from different geographic settings. We identified a genetic signature of EAEC which could comprise of E. coli strains harboring the EAEC transcriptional activator and its adhesin dependent factors. Further, we found that EAEC strains harbor additional putative virulence genes previously reported in extraintestinal pathogenic E. coli (ExPEC) and, therefore, strains meeting the re-definition could be both enteric bacteria and urinary/systemic pathogens.

Introduction

Enteroaggregative E. coli (EAEC) has been implicated as a common cause of acute and persistent diarrhea [1,2] and as a cause of linear growth faltering among children in low-income countries [3]. The German outbreak of Shiga toxin (Stx)–producing O104:H4 EAEC highlights the epidemiologic and genomic plasticity of this pathotype [4]. Since its initial description, EAEC has been defined as E. coli that do not express the enterotoxins of enterotoxigenic E. coli (ETEC), and which adhere to HEp-2 epithelial cells in an aggregative (AA) phenotype [5]. As such, EAEC stands alone among the DEC groups in employing a phenotypic, rather than genotypic, definition. Unfortunately, as nearly all DEC detection is currently accomplished using gene detection, the lack of a formally recognized genetic definition for EAEC serves to impede its epidemiologic investigation.

EAEC pathogenesis is thought to comprise mucosal inflammation and epithelial damage [6], and strains express a heterogeneous array of putative virulence factors [711] encoded on the bacterial chromosome or the EAEC-specific pAA plasmid. Most EAEC strains harbor a transcriptional activator of the AraC/XylS class called AggR [12], which controls the expression of plasmid-borne and chromosomal genes; among the AggR-dependent factors are five known variants (designated I-V) of the aggregative adherence fimbriae (AAFs) [1318]. AAF mediate adherence to human mucosal sections and thereby, presumably, promote intestinal colonization [19]. AAFs may directly incite both cytokine release and the opening of epithelial tight junctions [20,21]. AggR activates expression of its own repressor, called Aar (AggR-activated regulator) [22]. AggR also activates expression of the genes encoding dispersin (aap), the dispersin translocator Aat, and the Aai chromosomal type 6 secretion system (aaiA-Y) [23]. EAEC strains often harbor a variable number of serine protease autotransporters of Enterobacteriaceae (SPATEs) [10], which are implicated in immune evasion, mucosal damage, secretogenicity, and colonization [24]. Notably, none of these AggR-dependent or AggR-independent factors are found in all EAEC isolates and, moreover, no single factor has ever been consistently implicated epidemiologically in EAEC diarrhea [7,8,25]. Strains harboring the AggR regulon or its constituents have been termed typical EAEC [26], and these strains were the focus of this work. Strains that adhere to HEp-2 cells but do not carry AggR-regulated genes have never been evaluated in human volunteer studies, and are therefore of uncertain pathogenicity.

In the current study, we employed whole genome sequence comparative genomics and functional characterization to examine the diversity of 97 EAEC strains isolated from Bangladesh, Mali or Mozambique in the course of a prospective multicenter case-control diarrhea study (Global Enteric Multi-Center Study, GEMS). Genomes were characterized using novel genome mining algorithms to identify virulence factors and to associate them with clinical outcome.

Methods

Ethics statement

This research involved genomic characterization of EAEC isolates obtained from participants in the Global Enteric Multicenter Study (GEMS). The ethical review methods for this study were described in detail [27].

Study design

Isolates comprised 97 strains (57 cases and 40 controls) from Bangladesh (15 cases and 11 controls), Mali (25 cases and 19 controls), and Mozambique (17 cases and 10 controls). The strains were isolated in the course of the GEMS multicenter case-control study [27]. Briefly, GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhea in children aged 0–59 months residing in censused populations at four sites in Africa and three in Asia. Children with moderate-to-severe diarrhea seeking care at health centers along with one to three randomly selected matched community control children without diarrhea were recruited. From patients with moderate-to-severe diarrhea and controls, both clinical and epidemiological data were obtained, as well as anthropometric measurements and a fecal sample to identify enteropathogens at time of enrolment. The isolates were identified at the study site as EAEC based on multiplex PCR [7] for aatA and aaiC. Strains were subsequently characterized by PCR for presence of a known AAF-encoding gene, in order to intentionally over-represent strains that did not possess one of the known AAF variants. The EAEC genomes were compared with a set of previously sequenced archetype E. coli strains (S1 Table).

Adherence to colonoid monolayers

Human colonoid line 75C was established from de-identified biopsy tissue from a healthy subject provided informed consent at Johns Hopkins University. All methods were carried out in accordance with guidelines and regulations approved by the Johns Hopkins University Institutional Review Board (IRB# NA_00038329). Colonoids were maintained as previously described [28]. Colonoid monolayers were cultured in a 96-well plate pre-coated with human collagen IV (30 μg/ml; Sigma-Aldrich, USA) until confluency and then differentiated for 3–4 days. EAEC strains were grown for 16–18 hours without shaking in DMEM-high glucose (Gibco). Approximately 1 x 106 CFUs were added to each well. After a 3 hour incubation, the monolayers were washed three times with PBS, lysed with 1% Triton X-100/PBS, and adherent bacteria were enumerated by dilution and plating on Luria agar.

HEp2 cell assay

Adherence of E. coli strains was assessed using HEp-2 cell monolayers as previously described [5].

Serotyping

Somatic (O) and flagella (H) antigens were identified as described [29]. In addition to a defined antigen number, several additional designations were included: (1) “O rough,” i.e. the boiled culture auto-agglutinated, suggesting absence of O antigen; (2) “O?,” i.e. it could not be determined whether the strain produces an O antigen (precipitation with Cetavlon indicating an acidic polysaccharide that could represent capsular K antigen); and (3) “O+,” i.e. the O antigen is present but could not be typed. Serotyping was performed at the International Escherichia and Klebsiella Centre (World Health Organization), Department of Microbiological Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.

Genomic methods

Genomic DNA was purified from the EAEC isolates using the DNeasy Blood and Tissue kit (Qiagen). Sequencing was carried out with the Illumina technology on a MiSeq sequencing machine, using the Nextera XT Library preparation protocol (Illumina) for obtaining paired-end reads of 150 bp or 250 bp. Raw data for all isolates were deposited at the European Nucleotide Archive (ENA).

WGS data were pre-processed employing a QC-pipeline (available at https://github.com/ssi-dk/SerumQC). Sequences were removed in the case of contamination with more than 5% of another genera and sequences representing isolates with genome sizes outside the range of 4.64 Mbp-5.56 Mbp. Sequences were removed from the dataset if assemblies comprised of > 350 contigs. De novo assembly was carried out using CLC Genomics Workbench 10.

Nanopore sequencing of pAA plasmid from strain C671-15

Three μg DNA was purified with a Qiagen-tip 100 Plasmid Midi Kit (#12145) and sequenced as previously described [30]. Base-calling was carried out using with Albacore v2.0.2. For long-read sequencing, plasmid DNA from strain C671-15 was isolated using a Qiagen-tip 100 Plasmid Midi Kit (#12145). Three μg of plasmid DNA was fragmented by ten passes through a size G23 needle. The library was constructed using the 1D Ligation Barcoding Kit (SQK-LSK108 and EXP-NBD103, Oxford Nanopore Technologies, Oxford, UK) with 'End-prep' incubations increased to 2x30 minutes and sequenced in an R9.4 flow cell (FLO-MIN106) with a MinION Mk1B (ONT). ONT’s Albacore v2.0.2 was used for base calling. ONT sequencing adaptors were removed with Porechop v0.2.0 [31]. Illumina reads were end-trimmed to q20 using Trimmomatic v0.36 [32]. The Hybrid assembly of Illumina and Nanopore reads, generated on NextSeq sequencing machines and ONT, were performed with Unicycler (v0.4.0) [33]. Using CLC Genomics Workbench (v10.1.1), inspection of BLAST-mapped Nanopore with reads longer than 10,000 bp confirmed the structure of the assembled plasmids. Likewise, CLC mappings of Illumina short-reads were inspected to correct eventual small-scale assembly errors (variants, homopolymers and INDELs).

Analysis using Center for Genomic Epidemiology mining tools

Assembled sequence data were analyzed using typing tools from the Center for Genomic Epidemiology (CGE) (DTU, Lyngby, Denmark) (https://cge.cbs.dtu.dk/services/). CGE contains databases for in silico multilocus sequence typing (MLST), serotyping (SerotypeFinder), virulence analysis (VirulenceFinder), fim-typing, and antibiotic resistance prediction (consisting of annotated allelic variants for genes encoding serotype, virulence factors and antimicrobial resistance, https://bitbucket.org/genomicepidemiology/workspace/projects/DB).

VirulenceFinder has just been updated and identifies 139 putative or confirmed virulence genes, of which 75 are DEC-associated, 44 are ExPEC-associated, and 20 are found in almost all E. coli strains, irrespective of pathotype; in addition to those genes we included another ~60 virulence and putative virulence genes found in DEC and ExPEC.

The various “finder” tools use a BLAST-based approach to detect the genes of interest in the de novo assembled genome, and subsequently identifies them against the appropriate reference database. Detection standard parameters were as follows: for VirulenceFinder and SerotypeFinder, 85% sequence identity and 60% sequence coverage; for ResFinder, 90% sequence identity and 60% sequence coverage; for FimTyper, 95% sequence identity and 60% sequence coverage; for MLSTFinder, using the seven loci (adk, gyrB, fumC, icd, mdh, purA, and recA) scheme. Results are listed in S2 Table.

Phylogenetic analysis

The 97 EAEC genomes analyzed in this study were compared with nine previously sequenced EAEC reference genomes, which include the five AAF fimbrial type reference isolates, JM221, 17–2, C227-11, TY-2482, 042, 55989, C1010-00, 34B, and C338-14, as well as 37 diverse E. coli and Shigella genomes (S1 Table) using the SNP-based In Silico Genotyper (ISG) as previously described [34]. ISG identified 234,371 conserved SNPs that were used to infer a maximum-likelihood phylogeny using RAxML v7.2.8, with the GTR model of nucleotide substitution, the GAMMA model of rate heterogeneity, and 100 bootstrap replicates. The phylogeny was midpoint-rooted and diagramed using the interactive Tree of Life software (iTOL v.3).

We investigated differences in gene content among the EAEC genomes sequenced in this study using large-scale BLAST score ratio (LS-BSR) analysis as previously described [35]; protein-coding reading frames were predicted in each of the EAEC genomes using Prodigal [35]. Genes with a BSR ≥0.8 were considered to be positive. The presence of each gene or region among the EAEC genomes from cases and controls were analyzed for statistical significance using Fisher’s exact test.

Results

Frequency of AggR regulon-associated genes

To ascertain the distribution of EAEC-associated genes among the 97 isolates, we performed WGS and applied the E. coli genome mining algorithms VirulenceFinder 1.3, ResFinder 3.1, and SerotypeFinder 2.0 [36]. VirulenceFinder includes genes commonly found in Shiga-toxin producing E. coli (STEC), enteropathogenic E. coli (EPEC), Shigella/enteroinvasive E. coli (EIEC), and EAEC. We also performed BLAST search for virulence genes described in ETEC, diffusely adherent E. coli (DAEC), and extraintestinal pathogenic E. coli (ExPEC), which have not yet been included in the CGE VirulenceFinder (Table 1). Further, per study protocol, EAEC strains in GEMS possessed the plasmid-borne aatA and/or the chromosomal aaiC gene, thereby fulfilling the current criterion for typical EAEC strains; the aatA gene was found in 75% of strains, and the aaiC gene in 38%.

Table 1. Prevalence and Distribution of Putative Virulence Genes in 97 EAEC Isolates from Cases and Controls by Whole Genome Sequence.

Gene Gene description Pathotypea
Species
Case Control Total Odds Ratio
N = 57 (%) N = 40 (%) N = 97 (%)
aggR Transcriptional activator EAEC 45 (78.9) 36 (90.0) 81 (83.5) 0.4
aar AggR-activated regulator EAEC 27 (47.4) 29 (72.5) 56 (57.7) 0.3
aaiC AaiC, secreted protein EAEC 21 (36.8) 16 (40) 37 (38.1) 0.9
aap Dispersin, antiaggregation protein EAEC 48 (84.2) 38 (95.0) 86 (88.7) 0.3
aatA Dispersin transporter protein EAEC 40 (70.2) 33 (82.5) 73 (75.3) 0.5
aggA AAF/I fimbrial subunit EAEC 11 (19.3) 11 (27.5) 22 (22.7) 0.6
aafA AAF/II fimbrial subunit EAEC 3 (5.3) 5 (12.5) 8 (8.2) 0.4
agg3A AAF/III fimbrial subunit EAEC 3 (5.3) 6 (15) 9 (9.3) 0.3
agg4A AAF/IV fimbrial subunit EAEC 14 (24.6) 7 (17.5) 21 (21.6) 1.3
agg5A AAF/V fimbrial subunit EAEC 7 (12.3) 9 (22.5) 16 (16.5) 0.5
ORF3 Cryptic protein EAEC 37 (64.9) 33 (82.5) 70 (72.2) 0.4
ORF4 Cryptic protein EAEC 41 (71.9) 33 (82.5) 74 (76.3) 0.5
capU Hexosyltransferase homolog EAEC 36 (63.2) 31 (77.5) 67 (69.1) 0.5
air Enteroaggregative immunoglobulin repeat protein EAEC 11 (19.3) 6 (15) 17 (17.5) 1.4
eilA Salmonella HilA homolog EAEC 14 (24.6) 11 (27.5) 25 (25.8) 0.9
anr AraC Negative Regulators ETEC 1 (1.8) 1 (2.5) 2 (2.1) 0.7
sigA IgA protease-like homolog EAEC/EIEC 2 (3.5) 6 (15) 8 (8.2) 0
sepA Shigella extracellular protease EAEC/EIEC 27 (47.4) 7 (17.5) 34 (35.1) 4.2*
sat Secreted autotransporter toxin  EAEC/ExPEC 12 (21.1) 6 (15) 18 (18.6) 1.5
pic Serine protease precursor EAEC/EIEC 20 (35.1) 15 (37.5) 35 (36.1) 0.9
pet Plasmid-encoded toxin EAEC 4 (7) 4 (10) 8 (8.2) 0.7
espI Type III secreted proteins  EPEC 2 (3.5) 1 (2.5) 3 (3.1) 1.4
astA Heat-stable enterotoxin 1 EAEC 21 (36.8) 15 (37.5) 36 (37.1) 1
celB Endonuclease colicin E2 EPEC 1 (1.8) 3 (7.5) 4 (4.1) 0.2
clpK1 Clp ATPase and thermal stress survival Klebsiella 1 (1.8) 1 (2.5) 2 (2.1) 0.7
CS22 Colonization factors, CS22 ETEC 3 (5.3) 0 (0) 3 (3.1) ˗
iha Adherence protein STEC 11 (19.3) 15 (37.5) 26 (26.8) 0.4
ireA Siderophore receptor ExPEC 0 (0) 1 (2.5) 1 (1) 0.0
iss Increased serum survival ExPEC/APEC 27 (47.4) 10 (25) 37 (38.1) 2.7Δ
lpfA Long polar fimbriae STEC/EPEC 27 (47.4) 20 (50) 47 (48.5) 0.9
mchB Microcin H47 part of colicin H STEC/EPEC 10 (17.5) 13 (32.5) 23 (23.7) 0.4
mchC MchC protein STEC/EPEC 10 (17.5) 13 (32.5) 23 (23.7) 0.4
mchF ABC transporter protein MchF STEC/EPEC 11 (19.3) 12 (30) 23 (23.7) 0.6
mcmA Microcin M part of colicin H STEC/EPEC 7 (12.3) 3 (7.5) 10 (10.3) 1.7
nfaE Diffuse adherence fibrillar adhesin gene ETEC/DAEC 0 (0) 2 (5) 2 (2.1) 0.0
papGII P-fimbriae ExPEC 1 (1.8) 0 (0) 1 (1) ˗
papA P-fimbriae ExPEC 1 (1.8) 0 (0) 1 (1) ˗
sfaA S-fimbriae ExPEC 0 (0) 2 (5) 2 (2.1) 0.0
papC Pilus-associated protein C ExPEC 1 (1.8) 0 (0) 1 (1) ˗
chuA E. coli haem-utilization gene ExPEC 16 (28.1) 10 (25) 26 (26.8) 1.1
hra Heat-resistant agglutinin EAEC/ExPEC 10 (17.5) 9 (22.5) 19 (19.6) 0.8
iutA Aerobactin receptor ExPEC 5 (8.8) 3 (7.3) 8 (8.2) 1.1
KpsMII Translocate group II capsular polysaccharides ExPEC 23 (40.4) 12 (30) 35 (36.1) 1.6
kpsE Translocate group II capsular polysaccharides ExPEC 23 (40.4) 12 (30) 35 (36.1) 1.6
fyuA Yersiniabactin receptor ExPEC 37 (64.9) 19 (47.5) 56 (57.7) 2.0
iucC Aerobactin iron transport system ExPEC 32 (56.1) 21 (52.5) 53 (54.6) 1.2
sitA Iron caption system, Sit operon ExPEC/APEC 12 (21.1) 8 (20) 20 (20.6) 1.1
terC Tellurium ion resistance protein ExPEC 5 (8.8) 9 (22.5) 14 (14.4) 0.3
ompT Outer membrane protease gene ExPEC/APEC 15 (26.3) 4 (10) 19 (19.6) 3.2¤
aufA Fimbrial subunit ExPEC 5 (8.8) 2 (5) 7 (7.2) 1.8
yfcV Putative fimbriae ExPEC 3 (5.3) 1 (2.5) 4 (4.1) 2.1
senB Plasmid encoded enterotoxin STEC 4 (7) 3 (7) 7 (7.2) 0.9
tia Cell invasion determinant STEC/ETEC 16 (28.1) 12 (30) 28 (28.9) 0.9
tibA Autotransporter and afimbrial adhesin EPEC/ETEC 0 (0) 1 (2) 1 (1) ˗
tibC TibA glycosolator EPEC/ETEC 0 (0) 1 (2) 1 (1) ˗
Phylogenetic group        
A 19 (33.3) 10 (25) 29 (29.8) 1.5
B1 22 (38.6) 17 (42.5) 39 (40.2) 0.9
B2 1 (1.8) 1 (2.5) 2 (4.1) 0.7
D 14 (24.6) 9 (22.5) 23 (21.7) 1.1
E 0 (0) 2 (5) 2 (2.1) ˗
F 1 (1.8) 1 (2.5) 2 (4.1) 0.7
           

* 95% CI ⦋1.6–11.2⦌, χ2 9.2, p = 0.002. Δ 95% CI ⦋1.1–6.5⦌, χ2 4.98, p = 0.026. ¤95% CI ⦋0.98–10.56⦌, χ2 3.97, p = 0.046.P < .05 is significant. Fisher exact test was applied when the comparisons between cases and controls were <5 observations.

a pathotype or species most often associated with that particular gene. b Both EIEC and Shigella. EAEC, enteroaggregative E. coli. EIEC, enteroinvasive E. coli. ExPEC, extra-intestinal E. coli. EPEC, enteropathogenic E. coli. STEC, Shigatoxin producing E. coli. ETEC, enterotoxigenic E. coli. DAEC, diffusely adherent E. coli. APEC, avian patogenic E. coli.

Genome analysis suggested that the EAEC strains were mosaic in nature. The dispersin gene, aap, was the most frequently detected among all EAEC (89%), followed by aggR (84%), and the genes encoding the proteins ORF4 (76%) and ORF 3 (72%) (Table 1). As shown in Table 1, and previously reported, there was a high degree of concordance between genes known to comprise the AggR regulon [7,14,37,38]; such was not the case for two additional AggR regulated genes, aar (58%) and aaiC (38%).

Allelic diversity of Aggregative adherence Fimbria (AAF) pilin-encoding genes

Fundamental to EAEC pathogenesis is colonization of the intestinal mucosa, thought to be mediated by AAF, of which five distinct variants have been described. We found evidence of a known AAF variant in 71 (73%) of EAEC strains. The AAF/I cluster was most frequently observed in our collection (in 23%), followed by AAF/IV (22%), AAF/V (16%), AAF/III (9%), and AAF/II (8%). Importantly, we did not observe the presence of any previously unreported AAF variants.

The AAF adhesins are encoded by a four gene cluster [39], which is phylogenetically related to the usher-chaperone family of fimbriae. The AAF/I-encoding genes comprise, in order, aggD (chaperone), aggC (usher), aggB (minor pilin) and aggA (major pilin). This gene order was preserved in all AAF/I, III, IV and V clusters (Fig 1). In contrast, the published organization of AAF/II comprises two separate clusters (aafDA and aafCB), located at a significant distance on the pAA plasmid; this organization was observed for all eight AAF/II variants in the present analysis.

Fig 1. Annotation of the AAF/I-V and CS22-like biogenesis gene clusters, and adjacent genes, as determined by nucleotide sequence analysis of the product amplified from prototype strains JM221, 042, 55989, C1010-00, C338-14, and C671-15.

Fig 1

Organization of the CS22-like gene cluster differs from AAF variants I, III-V in that the predicted minor pilin gene, afaD, is located adjacent to the usher-encoding gene (sefC) and not the major pilin gene. All ORFs encoding >50 predicted amino acids are indicated. The nucleotide positions of the predicted translational start and stop codons are also indicated. We performed phylogenetic analysis of the predicted mature major pilin proteins (the basis for assigning AAF variants). Overall, the minimum amino acid similarities of the major pilin genes within each AAF variant were as follows: AAF/I (aggA), 64%; AAF/II (aafA), 80%; AAF/III (agg3a), 85%; AAF/IV (agg4a), 80%; and AAF/V (agg5a), 80%. Amino acid identities of the major pilin proteins between any two major variants was less than 25% (S3 Table). Variation within aggA alleles identified three sub-clusters (Fig 2), designated here as subgroups a, b and c. The similarity within the three sub-clusters was high: subgroup a, 94%; subgroup b, 91%; and subgroup c, 77%.

Fig 2. Neighbor-joining tree analysis of the predicted pilin protein of AAF/I-V and CS22.

Fig 2

Pilin-encoding gene sequences were extracted from the EAEC isolates, translated, and truncated at the sites of proven or predicted signal peptidase cleavage. The three distinct subgroups of AggA alleles, designated as subgroups a, b and c, are shown. Derived amino acid sequences were aligned using ClustalW and an unrooted phylogram including weighted branch lengths was plotted using iTOL software.

Nineteen strains (20%) were negative for any genes attributed to the known AAF variants; ten of those where positive for the chromosomally-encoded gene aaiC, and eight of these were negative for pAA-encoded genes, including aggR. Two aaiC positive- but AAF-negative strains, C251-15 and C693-09, harbored aggR and several aggR-regulated genes. Six of the nine AAF- and aaiC-negative strains harbored the aggR gene and three of those had the same virulence profile (aap, aatA, aggR, air, capU, chuA, eilA, gad, iss, kpsE, kpsMII, ompT, sepA) and all belonged to serotype O166:H15. Finally, the last three strains harbored a small number of aggR-regulated genes (aap, capU, ORF3, and ORF4).

To ascertain if the 19 AAF-negative strains manifested the defining AA phenotype, we performed the HEp-2 adherence assay. None of the strains exhibited the AA pattern. Of all the strains assayed only three strains adhered to the cells but not with an AA pattern and one strain, C682-15, was cytotoxic. This indicates that they would not be considered EAEC under the current definition.

We observed five different alleles of aar (here designated aar1-5), encoding the AggR anti-activator, with a predicted overall protein identity of 88%. These Aar alleles segregated according to specific AAF variants; e.g. Aar5 was only found among strains harboring AAF/II (S2 Table). Notably, all AAF/IV-producing strains lacked aar.

A new gene-cluster in EAEC

Given the importance of adhesion in EAEC pathogenesis, we examined more closely strains negative for the five known AAF variants, but harboring the AggR regulator and other pAA-borne genes. We thereby identified three strains (C719-09, C287-15, and C671-15) whose genomes harbored a similar non-AAF fimbrial biogenesis gene cluster; the genes are predicted to assemble a more distant member of the chaperone-usher adhesin family. The cluster comprised four genes: the gene encoding the non-fimbrial ETEC colonization factor (CF) pilin protein called CS22 [40], predicted fimbrial chaperone and usher genes sefB and sefC originally described in Salmonella enterica serovar Enteritidis gene cluster sefABCDE [41,42], and a minor predicted fimbrial subunit annotated as “AfaD-like” in GenBank (NCBI Reference Sequence: WP_096960972.1). The organization of the CS22-like gene cluster, as determined by nucleotide sequence analysis of the product amplified from strain C671-15, is shown in Fig 1. Organization of the CS22-like gene cluster differs from AAF variants I, III-V in that the predicted minor pilin gene, afaD, is located adjacent to the usher-encoding gene (sefC) and not the major pilin gene. When comparing amino acids from the predicted CS22-like protein individually to other members of the Dr family of adhesins as well as to the AAF pilins, the predicted pilin displayed the following closest percent similarities: 24% with AfaE-8 and M-agglutinin; 23% with BmaE and AfaE-V; 22% with AfaE-I; and 20% with DraE. The similarity with the AAF archetype pilins were at most 14% (S3 Table). We have previously noted that AAF pilins exhibit an unusually high predicted pI (>8.0) [14]; the CS22-encoding gene displayed a low predicted pI of 6.0. Therefore, the CS22-like pilin cannot be considered a novel AAF pilin.

To yield additional insights into these strains, we sequenced and annotated the entire 143 kb pAA plasmid from the CS22-like containing strain C671-15 (pAAC671-15) by using a MinION Mk1B (ONT) (S1 Fig). Beside the CS22-like fimbrial cluster, the pAAC671-15 plasmid harbored several genes reported as putative EAEC virulence factors: aar, aggR, aatABCDP, aap, sepA, and two copies of astA.

To establish the prevalence of the CS22-like gene cluster among EAEC strains, we screened 469 aggR positive strain genomes available in EnteroBase [43], and identified 25 strains (~ 5%) positive for EAEC CS22-like gene cluster when we employed an aa 85% identity threshold and 60% minimum alignment length (S3 Table). The alignment of the CS22-like peptide from all such strains revealed an aa identity of 83.74%-100%. The virulence gene combinations and serotypes of C719-09, C287-15, and C671-15 could be found among the 25 strains from EnteroBase (i.e., O39:H49, O9:H12; aaiC, aap, aar, aatA, aggR, astA, lpfA, pic, iss, sepA. Notably, all CS22-like positive strains were positive for astA, sepA, aggR, and aar, the latter two being 100% identical on the nucleotide level. These data suggest that strains harboring the CS22-like adhesin are characteristically typical EAEC by genomic criteria.

Importantly, the CS22-like strains were negative for adherence to HEp-2 cells (see above). To ascertain if these strains were able to adhere to the human intestinal epithelium, we incubated CS22-like archetype strain, C671-15, with human colonic organoids and compared their ability to adhere with that of EAEC strain 042. As shown in Fig 3, adherence between the two stains was nearly equivalent, and both adhered significantly more than an aafA null mutant [44] that exhibits adherence defects in this model system [45,46].

Fig 3. Adherence to colonoid monolayers.

Fig 3

Colonoids monolayers were incubated with EAEC strains for 3 hours, and then adherent bacteria were enumerated. One-way ANOVA was performed on log-transformed data followed by Tukey’s test for multiple comparisons. Adherence by strains 042 and C671-15 was not significantly different, but both strains adhered more than 042 aafA (**** p≤ 0.0001). Data shown are from two independent experiments.

Prevalence and distribution of putative virulence genes

Seeing EAEC is highly heterogeneous with regard to putative EAEC virulence factors, we expanded our genomic search to include virulence genes from DEC and ExPEC. Among our 97 genomes, we noted the presence of a substantial number of genes characteristically associated with other E. coli pathotypes, such as STEC, ETEC and extraintestinal pathogenic E. coli (ExPEC) (Table 1). ExPEC genes found among the EAEC strains included i) yersiniabactin receptor-encoding gene fyuA (58%); ii) increased serum survival-encoding gene, iss (38%); iii) aerobactin iron transport system-encoding gene, iucC; iv) translocate group II capsular polysaccharide-encoding genes kpsMII and kpsE (both 36%); v) haem- utilization-encoding gene chuA (27%); vi) iron caption system-encoding gene, sitA (20%); vii) heat-resistant agglutinin-encoding gene, hra and viii) the outer membrane protease-encoding gene ompT (both 19%); ix) putative fimbria-encoding gene, yfcV (4%); and x) afimbrial adhesion regulator-encoding gene, afaA-III (2.1%). The STEC and ETEC virulence genes also found in the EAEC isolates were i) long polar fimbriae lpfA (48.5%); ii) cell invasion determinant tia (29%); iii) irgA homologue adhesin iha (27%); and iv) microcin, mchB (23.7%). LpfA was the only virulence factor to differ in frequency between the phylogenetic groups, as it was found in all B1 isolates, Phylogroup D (only lineage 2, see Fig 4), and phylogroup F. Seven strains (7%), including archetype strain 042, harbored the ExPEC fimbrial aufA gene, and these strains were also only found in Phylogroup D lineage 2.

Fig 4. Phylogenomic analysis of the EAEC genomes.

Fig 4

The whole-genome phylogeny was constructed from 234,371 conserved SNP sites per genome that were identified compared against the reference genome E. coli strain IAI39 (GenBank accession no. NC_011750.1). The color of the isolate name indicates if it is a case (red), control (green), reference EAEC (blue) or reference E.coli (black). The phylogeny is decorated further with the geographic origin of the isolates by the colored balls outside of each isolate label. The isolates from Mali have a red ball, Mozambique, a yellow ball and Bangladesh, a purple ball. The outermost balls for labeling indicate the presence of the AAF fimbriae. The colors for each of these genomic regions are included in the inset legend. Three isolates are indicated as containing a CS22-like gene cluster, originally described in ETEC isolates [40] by an arrow in the outer ring of labels. The E. coli phylogroups are designated by letters (A, B1, B2, D, E, and F) on the interior of the phylogeny based on the inclusion of the reference isolates, as well as colored sections within the figure (Phylogroup A–aqua; Phylogroup B1 yellow; Phylogroup D is separated into three sub-clusters of EAEC isolates (grey, blue and violet), with only the blue sub-cluster containing reference isolates. The tree scale indicates the distance of 0.1 nucleotide changes per site. Bootstraps values ≥80 are indicated by black circles.

Of the five genes encoding the SPATEs most commonly found in EAEC, the most frequent among our strains were pic (at 36.1%) and sepA (35%). The least common SPATEs were pet and sigA (both 8%)(Table 1). There was general concordance of SPATE genes with AAF variants; e.g. sepA was characteristically found among strains that harbored AAF/IV, and of the 34 sepA-positive strains, 20 harbored AAF/IV.

Serotypes and antimicrobial characteristics

Several serotypes are considered to be markers of pathogenic E. coli and therefore are routinely screened for in public health and food industry settings. To ascertain the relationship between virulence factors and serotype, we applied both conventional and in silico serotyping. The 97 EAEC strains belonged to a diverse range and combination of O:H and phylogenetic types (S2 Table). Some O:H combinations were common, such as O153:H30 (seven strains), O166:H15 (six strains) and O99:H33 (six strains). The most common sequence type (ST) was ST10 (ten strains), followed by ST38 (seven strains), ST349 (six strains), and ST484, ST678, and ST841 (four strains each). Strains with the same serotype and ST typically harbored the same set of virulence factors. Notably, O166:H15 (ST 349) has been found in EAEC bloodstream isolates from children in Mozambique [47], and was previously implicated in a diarrheal outbreak in Japan [48].

The most commonly found H types were H30 and H4 (10 strains each), H12, H15, H27, H16 (seven strains each) and H33 (six strains). Half of the H4 strains belonged to phylogenetic group B1 and ST678, which forms a clonal group including the EAEC outbreak strain O104:H4 (Fig 4).

The majority of isolates (~80%) harbored genes conferring resistance to three or more groups of antibiotics (S2 Table). Six EAEC isolates harbored the common blaCTX-M-15gene [49].

Phylogenomic analysis of the EAEC genomes

Generally, E. coli can be divided into seven phylogenetic groups (A, B1, B2, C, D, E, F) [50]. Forty-two percent (39 strains) of the sequenced EAEC strains belonged to the phylogroup B1, followed in frequency by phylogroup A (29 strains) and phylogroup D (23 strains) (S1 Table and S2 Table). Strains belonging to group A harbored the majority of the AAF-negative strains (13/19 strains) (Fig 4). Among the phylogroup D strains, there were three clearly defined subgroups, designated lineages 1–3. In lineage 1, all strains possessed the O166:H15 serotype and ST349 (purple); lineage 2 strains included serogroups O44 (including type strain 042), O73 and O17/O77, in combination with H18 or H34 and belonging to ST130 or NT (blue). Among lineage 3, the majority (five strains) of strains exhibited the O153:H30 serotype and ST 38 (grey).

Genomic epidemiology of EAEC in cases of MSD

We hypothesized that EAEC isolated from cases of MSD would harbour virulence factors distinct from, or more commonly than, strains isolated from asymptomatic controls. We assessed the correlation of all AggR-dependent and SPATE-encoding genes with clinical state (Table 1) by applying Fisher’s exact test. Of all genes scored, sepA yielded the strongest association with MSD: 27 sepA-positive strains originated from MSD cases and seven from controls, yielding an OR of 4.2 (P = 0.002) (Table 1). When assessing the correlation with MSD for all other genes assayed, we found that the increased serum survival gene, iss, and the outer membrane protease gene, ompT, were each significantly associated with MSD (p = 0.026 and p = 0.046, respectively) (Table 1); Iss has been recognized for its role in ExPEC virulence [5153]. We observed six distinct alleles of the iss gene, and three of those variants (found in seven cases) had a short signal peptide, similar to the phage λ gene bor [54]. The similarity between the predicted proteins from iss and bor was 92.59%. Overall, we identified 105 features that were statistically (FDR p value < 0.05) associated with symptomatic EAEC (S4 Table) and 225 features that were statistically associated with the asymptomatic EAEC (S4 Table).

Discussion

Since the initial description of EAEC, a large number of putative virulence EAEC factors have been described. However, EAEC strains have manifested striking mosaicism and marked genomic heterogeneity, even among strains from a single epidemiologic site. Moreover, the proliferation of potential virulence factors has not yielded an improved definition of this emerging pathotype.

The most important advance in understanding the genomics and pathogenicity of EAEC has been the description of the AggR regulon. Strains harboring AggR have been termed typical EAEC [26], and most studies employing molecular diagnostics have targeted such strains. Given the challenges to performing the HEp-2 adherence assay in clinical laboratories, detection of various AggR-associated genes has served as the de facto standard for EAEC epidemiology, despite the lack of formal analysis substantiating this approach.

In this study, we generated the most definitive characterization to date of the pan-genome of EAEC by performing WGS on a diverse collection of strains isolated from different geographic settings, and compared these genomes with already available genomes from strains isolated from around the world. All strains harbored at least one gene shown to be under the control of AggR; the strains are thus representative of isolates that are currently considered to be EAEC in clinical and epidemiologic studies (and are typical EAEC in the formal definition).

We report here that among the isolates analyzed, all strains meeting the current definition of EAEC (adherence to HEp-2 epithelial cells) possessed one of the five reported AAF variants; strains lacking an identifiable AAF, including those harboring the CS22-like cluster, did not yield the aggregative pattern, even if they harbored AggR or other AggR-associated genes. These data suggest for the first time a molecular definition of EAEC: we propose to define EAEC as E. coli strains harboring AggR and a complete cluster of AAF-encoding genes (usher, chaperone, and both major and minor pilin subunit genes) or CS22. By applying this new definition to our strain collection, 76% (74 strains) fit the criteria (S2 Table); the other 24% characteristically harbored only a small subset of putative virulence-associated genes. Although some strains not meeting this definition may be human pathogens, we believe that they will display different clinical, epidemiologic and pathogenetic characteristics compared with true EAEC, and therefore, they should be excluded from the EAEC appellation. Whether such non-EAEC strains will ultimately merit assignment to a new pathotype will depend on future data that suggest a definitive association with human disease.

EAEC in general was not associated with MSD in the GEMS study. To profile the virulence genes of our strain set, we blasted our 97 EAEC genomes for ~200 virulence and putative virulence genes found in DEC and ExPEC. As previously reported we found our EAEC strains to be highly diverse. Therefore, we quantified the strength of the association between cases and control calculating the odds ratio (OR). Few of the virulence genes described in Table 1 were themselves associated epidemiologically with disease. The strongest association was for the SepA protease, which has previously been associated with disease epidemiologically [7]. Interestingly, we also found an association of the iss gene and ompT. Both genes play a role in the ability of the bacterium to resist the killing effects of the host immune system: OmpT is responsible for protamine inactivation [55] and the iss gene confers complement resistance [56]. iss has been found to be associated with E. coli isolated from female patients with bacteremia of urinary tract origin [51] and it has been suggested that OmpT plays a multifaceted role in the pathogenesis of urinary tract infections contributing to urovirulence [57,58]. Notably, 15.5% (15 strains) of the EAEC strains harbored both the iss and the ompT genes, and this pattern was strongly associated with MSD (p = 0.017). Thirteen of these 15 dual-positive strains fit our proposed modified definition of EAEC; eleven of these strains belonged to uncommon serotypes such as O154:H21 (ST 40) and O7:H4 (ST 484) suggesting the existence of pathogenic clones. Notably, our strains belonged to 43 different ST types, including ST10, ST38, ST40, ST131, ST678, which have all been described as either statistically associated with EAEC disease or implicated in EAEC outbreaks [4,5961].

Consistent with the implication of iss and ompT, we report that EAEC strains harbor additional putative virulence genes previously reported in ExPEC and avian pathogenic E. coli (APEC), and indeed EAEC strains have been implicated in urinary tract infection (UTI) [60] and bacteremia in children under five years of age [47]. A recent study reported that EAEC with ExPEC markers were distributed into three distinct phylogenetic branches [62]. The authors of this report suggested that phylogenetic group A EAEC with ExPEC markers are potential agents of UTI; in our analysis, however, we observed ExPEC markers across all phylogenetic groups. It is possible that both authentic enteric and urinary/systemic pathogens can be found among strains meeting the definition of EAEC.

The natural history of EAEC can be illuminated by global genomic analysis, whereas EAEC vaccine development will require a detailed understanding of antigenic diversity. Both areas of discussion have been advanced by our analysis. Most importantly, our data suggest that AAF adhesins may be promising immunogens based on their high prevalence and generally high amino acid conservation. As seen for other pathotypes, the most common EAEC serotypes featured characteristic combinations of putative virulence-associated genes. For example, all AAF/IV-producing strains lacked the aar gene (which is associated with down-regulation of the AggR regulon), and such strains commonly harbored the SepA-encoding gene. Such clones may be more diarrheagenic than other EAEC. Despite different geographic origins, all AAF/II-producing strains harbored a discontinuous fimbrial biogenesis genetic organization, as first described for the Peruvian archetype strain 042 [63].

EAEC remains a common bacterium associated with diarrhea and linear growth faltering among children in developing countries, and increasingly with extra-intestinal disease. Our analyses may aid epidemiologic investigation, vaccine development, and clinical characterization of this pathogen.

Supporting information

S1 Fig. Annotation of the 143,612 bp pAA plasmid from Strain C671-15 with a MinION Mk1B (ONT).

The plasmid was annotated using Rast as well as manual BLAST searches. Known virulence and putative virulence genes are shown in red. Other genes and open reading frames are shown in blue.

(TIF)

S1 Table. List of E. coli and Shigella reference genomes included in the phylogenomic analysis of the EAEC genomes.

(XLSX)

S2 Table. Genomic characteristics and description of the 97 EAEC strains and six references EAEC strains including; isolate number, country, type/ condition, pathotype, phylogroup, AAF/ adhesin, putative virulence genes, serotype, fimH, Aar variant, MLST ST(CC), antibiotic resistance genes, accession number, and number of contigs.

(XLSX)

S3 Table. Comparisons of amino acids from the predicted CS22-like protein individually to other members of the Dr-family of adhesins as well as to the AAF pilins.

(XLSX)

S4 Table. Large-scale BLAST score ratio (LS-BSR) analysis of the 97 EAEC genomes: identifying 105 features that were statistically (FDR p value < 0.05) associated with symptomatic EAEC and 225 features that were statistically associated with the asymptomatic EAEC.

(XLSX)

Acknowledgments

We thank Susanne Jespersen Statens Serum Institut for laboratory support. We also thank Dr. Jorge Giron, University of Virginia, School of Medicine for performing the Hep2 cell adherence assay.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was supported by DFF1333-00156 to N.B.O and The National Institutes of Health grants AI-033096 and AI-125181 to J. P. N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Okeke IN, Lamikanra A, Steinrück H, Kaper JB. Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria. J Clin Microbiol. 2000;38: 7–12. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=86005&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Valentiner-Branth P, Steinsland H, Fischer TK, Perch M, Scheutz F, Dias F, et al. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol. 2003;41: 4238–45. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=193811&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rogawski ET, Guerrant RL, Havt A, Lima IFN, Medeiros PHQS, Seidman JC, et al. Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort. PLoS Negl Trop Dis. 2017;11 10.1371/journal.pntd.0005798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Scheutz F, Nielsen EM, Frimodt-Møller J, Boisen N, Morabito S, Tozzoli R, et al. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 2011;16 Available: http://www.ncbi.nlm.nih.gov/pubmed/21699770 [DOI] [PubMed] [Google Scholar]
  • 5.Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J. 1987;6: 829–31. Available: http://www.ncbi.nlm.nih.gov/pubmed/3313248 [DOI] [PubMed] [Google Scholar]
  • 6.Boisen N, Hansen A-M, Melton-Celsa AR, Zangari T, Mortensen NP, Kaper JB, et al. The Presence of the pAA Plasmid in the German O104:H4 Shiga Toxin Type 2a (Stx2a)-Producing Enteroaggregative Escherichia coli Strain Promotes the Translocation of Stx2a Across an Epithelial Cell Monolayer. J Infect Dis. 2014. [cited 15 Nov 2014]. 10.1093/infdis/jiu399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Boisen N, Scheutz F, Rasko D a, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205: 431–44. 10.1093/infdis/jir757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lima IFN, Boisen N, Quetz J da S, Havt A, de Carvalho EB, Soares AM, et al. Prevalence of enteroaggregative Escherichia coli and its virulence-related genes in a case-control study among children from north-eastern Brazil. J Med Microbiol. 2013;62: 683–693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB, Nataro JP. Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria. J Infect Dis. 2000;181: 252–60. 10.1086/315204 [DOI] [PubMed] [Google Scholar]
  • 10.Boisen N, Ruiz-Perez F, Scheutz F, Krogfelt KA, Nataro JP. Short report: high prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am J Trop Med Hyg. 2009;80: 294–301. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2660206&tool=pmcentrez&rendertype=abstract [PMC free article] [PubMed] [Google Scholar]
  • 11.Jenkins C, van Ijperen C, Dudley EG, Chart H, Willshaw GA, Cheasty T, et al. Use of a microarray to assess the distribution of plasmid and chromosomal virulence genes in strains of enteroaggregative Escherichia coli. FEMS Microbiol Lett. 2005;253: 119–24. 10.1016/j.femsle.2005.09.040 [DOI] [PubMed] [Google Scholar]
  • 12.Nataro JP, Yikang D, Yingkang D, Walker K. AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J Bacteriol. 1994;176: 4691–9. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=196291&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bernier C, Gounon P, Le Bouguénec C. Identification of an aggregative adhesion fimbria (AAF) type III-encoding operon in enteroaggregative Escherichia coli as a sensitive probe for detecting the AAF-encoding operon family. Infect Immun. 2002;70: 4302–11. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=128174&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Boisen N, Struve C, Scheutz F, Krogfelt KA, Nataro JP. New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family. Infect Immun. 2008;76: 3281–92. 10.1128/IAI.01646-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Czeczulin JR, Balepur S, Hicks S, Phillips A, Hall R, Kothary MH, et al. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun. 1997;65: 4135–45. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175595&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Henderson IR, Hicks S, Navarro-Garcia F, Elias WP, Philips AD, Nataro JP. Involvement of the enteroaggregative Escherichia coli plasmid-encoded toxin in causing human intestinal damage. Infect Immun. 1999;67: 5338–44. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=96889&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nataro JP, Yikang D, Giron JA, Savarino SJ, Kothary MH, Hall R. Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun. 1993;61: 1126–31. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=302849&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jønsson R, Struve C, Boisen N, Mateiu RV, Santiago AE, Jenssen H, et al. A novel Aggregative Adherence Fimbriae (AAF/V) of Enteroaggregative Escherichia coli (EAEC). Infect Immun. 2015. [cited 15 Feb 2015]. 10.1128/IAI.02820-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Poole NM, Rajan A, Maresso AW. Human Intestinal Enteroids for the Study of Bacterial Adherence, Invasion, and Translocation. Curr Protoc Microbiol. 2018;50: e55 10.1002/cpmc.55 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Strauman MC, Harper JM, Harrington SM, Boll EJ, Nataro JP. Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun. 2010;78: 4958–64. 10.1128/IAI.00580-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Harrington SM, Strauman MC, Abe CM, Nataro JP. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol. 2005;7: 1565–78. 10.1111/j.1462-5822.2005.00588.x [DOI] [PubMed] [Google Scholar]
  • 22.Santiago AE, Ruiz-Perez F, Jo NY, Vijayakumar V, Gong MQ, Nataro JP. A large family of antivirulence regulators modulates the effects of transcriptional activators in Gram-negative pathogenic bacteria. PLoS Pathog. 2014;10: e1004153 10.1371/journal.ppat.1004153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dudley EG, Thomson NR, Parkhill J, Morin NP, Nataro JP. Proteomic and microarray characterization of the AggR regulon identifies a pheU pathogenicity island in enteroaggregative Escherichia coli. Mol Microbiol. 2006;61: 1267–82. 10.1111/j.1365-2958.2006.05281.x [DOI] [PubMed] [Google Scholar]
  • 24.Dutta PR, Cappello R, Navarro-García F, Nataro JP. Functional comparison of serine protease autotransporters of enterobacteriaceae. Infect Immun. 2002;70: 7105–13. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=133081&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ikumapayi UN, Boisen N, Hossain MJ, Betts M, Lamin M, Saha D, et al. Identification of subsets of enteroaggregative Escherichia coli associated with diarrheal disease among under 5 years of age children from Rural Gambia. Am J Trop Med Hyg. 2017;97 10.4269/ajtmh.16-0705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sarantuya J, Nishi J, Wakimoto N, Erdene S, Nataro JP, Sheikh J, et al. Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children. J Clin Microbiol. 2004;42: 133–9. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=321701&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382: 209–22. 10.1016/S0140-6736(13)60844-2 [DOI] [PubMed] [Google Scholar]
  • 28.Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, et al. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep. 2017;7 10.1038/srep45270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Orskov F, Orskov I. Escherichia coli serotyping and disease in man and animals. Can J Microbiol. 1992;38: 699–704. Available: http://www.ncbi.nlm.nih.gov/pubmed/1382824 [PubMed] [Google Scholar]
  • 30.Roer L, Overballe-Petersen S, Hansen F, Johannesen TB, Stegger M, Bortolaia V, et al. ST131 fimH22 Escherichia coli isolate with a blaCMY-2/IncI1/ST12 plasmid obtained from a patient with bloodstream infection: Highly similar to E. coli isolates of broiler origin. J Antimicrob Chemother. 2019;74: 557–560. 10.1093/jac/dky484 [DOI] [PubMed] [Google Scholar]
  • 31.Wick RR, Judd LM, Gorrie CL, Holt KE. Completing bacterial genome assemblies with multiplex MinION sequencing. Microb Genomics. 2017;3: e000132 10.1099/mgen.0.000132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30: 2114–20. 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. Phillippy AM, editor. PLOS Comput Biol. 2017;13: e1005595 10.1371/journal.pcbi.1005595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sahl JW, Beckstrom-Sternberg SM, Babic-Sternberg JS, Gillece JD, Hepp CM, Auerbach RK, et al. The In Silico Genotyper (ISG): an open-source pipeline to rapidly identify and annotate nucleotide variants for comparative genomics applications. bioRxiv. 2015; 015578 10.1101/015578 [DOI] [Google Scholar]
  • 35.Sahl JW, Caporaso JG, Rasko DA, Keim P. The large-scale blast score ratio (LS-BSR) pipeline: a method to rapidly compare genetic content between bacterial genomes. PeerJ. 2014;2: e332 10.7717/peerj.332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and Easy In Silico Serotyping of Escherichia coli Isolates by Use of Whole-Genome Sequencing Data. J Clin Microbiol. 2015;53: 2410–26. 10.1128/JCM.00008-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sheikh J, Czeczulin JR, Harrington S, Hicks S, Henderson IR, Le Bouguénec C, et al. A novel dispersin protein in enteroaggregative Escherichia coli. J Clin Invest. 2002;110: 1329–37. 10.1172/JCI16172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cerna JF, Nataro JP, Estrada-Garcia T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol. 2003;41: 2138–40. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=154749&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Nataro JP, Deng Y, Maneval DR, German AL, Martin WC, Levine MM. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun. 1992;60: 2297–304. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=257157&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pichel M, Binsztein N, Viboud G. CS22, a novel human enterotoxigenic Escherichia coli adhesin, is related to CS15. Infect Immun. 2000;68: 3280–5. Available: http://www.ncbi.nlm.nih.gov/pubmed/10816474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ogunniyi AD, Kotlarski I, Morona R, Manning PA. Role of SefA Subunit Protein of SEF14 Fimbriae in the Pathogenesis of Salmonella enterica serovar Enteritidis. Infect Immun. 1997. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC176117/pdf/650708.pdf [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Collighan RJ, Woodward MJ. The SEF14 fimbrial antigen of Salmonella enterica serovar Enteritidis is encoded within a pathogenicity islet. Vet Microbiol. 2001;80: 235–245. 10.1016/S0378-1135(01)00309-1 [DOI] [PubMed] [Google Scholar]
  • 43.EnteroBase. Available: http://enterobase.warwick.ac.uk/species/index/ecoli
  • 44.Izquierdo M, Navarro-Garcia F, Nava-Acosta R, Nataro JP, Ruiz-Perez F, Farfan MJ. Identification of cell surface-exposed proteins involved in the fimbria-mediated adherence of enteroaggregative Escherichia coli to intestinal cells. Infect Immun. 2014;82: 1719–24. 10.1128/IAI.01651-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rajan A, Vela L, Zeng XL, Yu X, Shroyer N, Blutt SE, et al. Novel segment- and host-specific patterns of enteroaggregative escherichia coli adherence to human intestinal enteroids. MBio. 2018;9 10.1128/mBio.02419-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gonyar LA, Smith RM, Giron JA, Zachos NC, Ruiz-Perez F, Nataro JP. Aggregative adherence fimbriae II of enteroaggregative Escherichia coli are required for adherence and barrier disruption during infection of human colonoids. Infect Immun. 2020. [cited 13 Jul 2020]. 10.1128/IAI.00176-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mandomando I, Vubil D, Boisen N, Quintó L, Ruiz J, Sigaúque B, et al. Escherichia coli st131 clones harbouring AGGR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of FIMH27 subclone. PLoS Negl Trop Dis. 2020;14: 1–21. 10.1371/journal.pntd.0008274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zhou Z, Ogasawara J, Nishikawa Y, Seto Y, Helander A, Hase A, et al. An outbreak of gastroenteritis in Osaka, Japan due to Escherichia coli serogroup O166:H15 that had a coding gene for enteroaggregative E. coli heat-stable enterotoxin 1 (EAST1). Epidemiol Infect. 2002;128: 363 Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869831/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol. 2014;4: 24555 10.3402/iee.v4.24555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo‐typing method revisited: improvement of specificity and detection of new phylo‐groups. Environ Microbiol Rep. 2013;5: 58–65. 10.1111/1758-2229.12019 [DOI] [PubMed] [Google Scholar]
  • 51.Skjøt-Rasmussen L, Ejrnæs K, Lundgren B, Hammerum AM, Frimodt-Møller N. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Int J Med Microbiol. 2012;302: 129–134. 10.1016/J.IJMM.2012.03.002 [DOI] [PubMed] [Google Scholar]
  • 52.Pfaff-McDonough SJ, Horne SM, Giddings CW, Ebert JO, Doetkott C, Smith MH, et al. Complement resistance-related traits among Escherichia coli isolates from apparently healthy birds and birds with colibacillosis. Avian Dis. 44: 23–33. Available: http://www.ncbi.nlm.nih.gov/pubmed/10737641 [PubMed] [Google Scholar]
  • 53.Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology. 2005;151: 2097–2110. [DOI] [PubMed] [Google Scholar]
  • 54.Johnson TJ, Wannemuehler YM, Nolan LK. Evolution of the iss Gene in Escherichia coli. Appl Environ Microbiol. 2008;74: 2360–2369. 10.1128/AEM.02634-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Stumpe S, Schmid R, Stephens DL, Georgiou G, Bakker EP. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol. 1998;180: 4002–6. Available: http://www.ncbi.nlm.nih.gov/pubmed/9683502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Binns MM, Davies DL, Hardy KG. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature. 1979;279: 778–781. 10.1038/279778a0 [DOI] [PubMed] [Google Scholar]
  • 57.He XL, Wang Q, Peng L, Qu Y-R, Puthiyakunnon S, Liu X-L, et al. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection. Pathog Dis. 2015;73 10.1093/femspd/ftv006 [DOI] [PubMed] [Google Scholar]
  • 58.Johnson JR, Kaster N, Kuskowski MA, Ling G V. Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infection. J Clin Microbiol. 2003;41: 337–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS, Hwang J, et al. Multi-locus sequence typing of enteroaggregative escherichia coli isolates from nigerian children uncovers multiple lineages. PLoS One. 2010;5 10.1371/journal.pone.0014093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, Krogfelt KA. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immun. 2013;81: 1164–71. 10.1128/IAI.01376-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Olesen B, Scheutz F, Andersen RL, Menard M, Boisen N, Johnston B, et al. Enteroaggregative Escherichia coli O78:H10, the Cause of an Outbreak of Urinary Tract Infection. J Clin Microbiol. 2012;50: 3703–3711. 10.1128/JCM.01909-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Nunes KO, Santos ACP, Bando SY, Silva RM, Gomes TAT, Elias WP. Enteroaggregative Escherichia coli with uropathogenic characteristics are present in feces of diarrheic and healthy children. Pathog Dis. 2017;75 10.1093/femspd/ftx106 [DOI] [PubMed] [Google Scholar]
  • 63.Elias WP, Czeczulin JR, Henderson IR, Trabulsi LR, Nataro JP. Organization of biogenesis genes for aggregative adherence fimbria II defines a virulence gene cluster in enteroaggregative Escherichia coli. J Bacteriol. 1999;181: 1779–85. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=93575&tool=pmcentrez&rendertype=abstract [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008613.r001

Decision Letter 0

Ana LTO Nascimento, Claire Jenkins

6 Jul 2020

Dear Dr. Boisen,

Thank you very much for submitting your manuscript "Redefining enteroaggregative Escherichia coli (EAEC): Genomic Characterization of Epidemiological EAEC Strains" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Claire Jenkins

Guest Editor

PLOS Neglected Tropical Diseases

Ana LTO Nascimento

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Methods are appropriate and well described for the most part.

Reviewer #2: The objectives and the end outcome of the study needs to be better articulated. The authors have substantial work done but the objective for each section needs to be stated clearly.

Reviewer #3: Yes to all the questions.

See the attachment for other suggestions.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The results are clearly and transparently presented and weaknesses appropriately identified.

The supplementary tables did not convert well into PDF, and as a result, the final PDF file has what appears to be 100s of pages of empty space.

Reviewer #2: Explain and define what is a control strain and how is it different from case strain?

The results can be divided into sections and subsections each explaining a group of idea. Introduce in a line or two why what is done in the results sections so that it is each to follow the process.

Table 1: The legend needs to describe the method used and what is been shown in the table.

Table 1: In the text please describe the odds ratio and why is it imp.

Reviewer #3: Yes to all the questions.

The results of the assay of adherence of colonoid monolayers are not properly clear.

See the attachment for other suggestions.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusions are well supported, although the recommendation for reclassification of EAEC based on this paper may require further supportive data.

Reviewer #2: (No Response)

Reviewer #3: Yes to all the questions.

See the attachment for other suggestions.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: In figure 4, the color shading of the phylogenetic groups themselves is not explained in the legend. I am assuming the colors were put in just to provide visual clarity about the separation of the groups, but given that the rest of the color schemes were clearly described, this became a bit confusing.

In Figure 3, the statistics should be shown on the figure itself.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This manuscript by Dr. Nadia Boisen et al describes a thorough genomic characterization of E. coli isolates characterized as EAEC based on molecular criteria from the MAL-ED study. This is an important work in the field, as heterogeneity of EAEC has complicated clinical studies for years. The most interesting finding is that of a previously unrecognized cluster of EAEC-like organisms that express the CS22 colonization factor associated with ETEC instead of AAF adhesins. The authors propose that the current molecular characterization of EAEC be expanded to include these strains, despite their lack of aggregative adherence on HEp-2 cells, based in part on their identification in children with diarrhea, and their adherence to human colonoids in vitro.

The work as a whole is very thorough and transparently presented. The proposed reclassification is likely to engender good discussion among experts in the field, and might not be fully justified based on this current study, without further characterization in vitro and further work to associate these CS22 strains with disease (which can likely be done in the future in retrospective studies using isolates and clinical data from other longitudinal cohorts).

To improve the manuscript, I would suggest the following revisions:

1. In tables 1 and S4, there does not appear to have been a multiple comparisons correction used. I would recommend a statistical review to help determine whether this is needed in this case.

2. Table S4 lacks labeling of the columns to make the interpretation clear.

3. The “negative” Hep2 assay (lines 197-199) does not describe whether these isolates demonstrated any mannose-resistant adherence at all, or just not an aggregative pattern. Based on the discussion later on, it appears that there was no adherence at all, but this should be stated in the results section.

4. In the colonoid assays, I would like to know how other WT strains (e.g. HS and other nonpathogenic commensals) adhere in comparison to the three isolates shown in figure 3; i.e. is this specific to pathogenic strains? If not, then colonoid adherence may not be enough to put CD22 strains into the same pathogenic class as Hep-2-adherent strains. I’m also a bit surprised the authors didn’t cite the 2018 mBio paper (PMID: 29463660) that showed donor- and segment-specific differences in adherence to intestinal organoids.

Reviewer #2: A general schematic or figure summarizing the goal/objective and workflow would help in better comprehension of the paper.

Reviewer #3: (No Response)

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Theodore S. Steiner

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008613.r003

Decision Letter 1

Ana LTO Nascimento, Claire Jenkins

20 Jul 2020

Dear Dr. Boisen,

We are pleased to inform you that your manuscript 'Redefining enteroaggregative Escherichia coli (EAEC): Genomic Characterization of Epidemiological EAEC Strains' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Claire Jenkins

Guest Editor

PLOS Neglected Tropical Diseases

Ana LTO Nascimento

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008613.r004

Acceptance letter

Ana LTO Nascimento, Claire Jenkins

31 Aug 2020

Dear Dr. Boisen,

We are delighted to inform you that your manuscript, "Redefining enteroaggregative Escherichia coli (EAEC): Genomic Characterization of Epidemiological EAEC Strains ," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Annotation of the 143,612 bp pAA plasmid from Strain C671-15 with a MinION Mk1B (ONT).

    The plasmid was annotated using Rast as well as manual BLAST searches. Known virulence and putative virulence genes are shown in red. Other genes and open reading frames are shown in blue.

    (TIF)

    S1 Table. List of E. coli and Shigella reference genomes included in the phylogenomic analysis of the EAEC genomes.

    (XLSX)

    S2 Table. Genomic characteristics and description of the 97 EAEC strains and six references EAEC strains including; isolate number, country, type/ condition, pathotype, phylogroup, AAF/ adhesin, putative virulence genes, serotype, fimH, Aar variant, MLST ST(CC), antibiotic resistance genes, accession number, and number of contigs.

    (XLSX)

    S3 Table. Comparisons of amino acids from the predicted CS22-like protein individually to other members of the Dr-family of adhesins as well as to the AAF pilins.

    (XLSX)

    S4 Table. Large-scale BLAST score ratio (LS-BSR) analysis of the 97 EAEC genomes: identifying 105 features that were statistically (FDR p value < 0.05) associated with symptomatic EAEC and 225 features that were statistically associated with the asymptomatic EAEC.

    (XLSX)

    Attachment

    Submitted filename: Letter to Reviewers_16072020.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES